Everything To Know About Mnet’s ‘PRODUCE 101 JAPAN SHINSEKAI’

From the same creators who brought BOYS II PLANET, PRODUCE 101 SHINSEKAI is the Japanese survival competition series for the ...
ANTARA News

Govt targets 101 Sekolah Rakyat units completion by June 2026

The government is targeting the completion of the second phase of Sekolah Rakyat (People's School) construction, reaching 101 ...
Business Wire

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

ZURICH--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis ...
WFTV

Disney Musicals in Schools program culminates in Endeavour Elementary’s ’101 Dalmatians KIDS’

BREVARD COUNTY, Fla. — Endeavour Elementary students will perform “101 Dalmatians KIDS” on Thursday at the Rockledge High School Auditorium. The event marks the culmination of a unique partnership ...
Hartford Courant

UConn women’s basketball sets program record with 20 3-pointers in 101-68 rout of Iowa State

UNCASVILLE — The UConn women’s basketball team dominated Iowa State 101-68 in the Basketball Hall of Fame Showcase on Tuesday night, setting a program record with 20 made 3-pointers in their ...
Mena FN

Piston Bio Announces FDA Alignment On PST-101 Development Program For Cancer-Related Apathy

(MENAFN- GlobeNewsWire - Nasdaq) MORRISTOWN, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Piston Bio LLC, a clinical-stage biotechnology company developing therapeutics targeting neuroimmune mechanisms in ...
Business Insider

Piston Bio Announces FDA Alignment on PST-101 Development Program for Cancer-Related Apathy

MORRISTOWN, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Piston Bio LLC, a clinical-stage biotechnology company developing therapeutics targeting neuroimmune mechanisms in cancer, today announced the ...
Finanznachrichten

NewcelX Ltd.: NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes

Collaboration Integrates Stem-Cell-Derived Islets with Targeted Immune Modulation ZURICH, Switzerland, March 9, 2026 /PRNewswire/ -- NewcelX Ltd. ("NewcelX") (Nasdaq: NCEL), a clinical-stage company ...
Seeking Alpha

NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes

ZURICH, Switzerland, March 9, 2026 /PRNewswire/ -- NewcelX Ltd. (NCEL), a clinical-stage company advancing stem-cell-derived therapies for Type 1 Diabetes, today announced a collaborative research ...